DO-BO

What Makes Australia’s HTA Approach to Equity and Health Productivity Unique, Zanfina Ademi?

In this Market Access Podcast episode, Dr. Stefan Walzer sits down with Prof. Zanfania Ademi, a health economist at Monash University, to explore how Australia’s healthcare system is tackling key issues in market access and health technology assessment. Discover how Australia blends international approaches and new methods being developed by Zanfina and her team like distributional cost-effectiveness and productivity-adjusted life years to advance equity and value in healthcare. Tune in for fresh insights on health as an investment, not just a cost,  and what’s next for decision-makers.

Key takeaways from the episode include the shift from qualitative to quantitative measures of equity in HTA, and the use of complex disease models and real-world evidence to drive smarter prevention strategies. The discussion also covers the growing recognition of both paid and unpaid work in productivity metrics, along with lessons from Switzerland on disinvestment, transparency, and the challenges of implementing new value measures in healthcare. Perfect for professionals in market access, health economics, and policy.

Related

In this episode of the Market Access Podcast, Erica Bersin – founder of ERO Health Communications – joins Dr. Stefan Walter to discuss the changing role of patient involvement in healthcare. Drawing on her experience in both Europe and the U.S., Erica explains how single-payer systems make patient engagement easier, while the U.S. faces more […]

In this episode of the Market Access Podcast, Dr. Stefan Walzer sits down with strategy consultant and XR advocate Günther Illert to explore how virtual, augmented, and extended reality are reshaping healthcare—from patient training and pain therapy to surgical planning and medtech education. Learn how cross-sector collaboration and early adoption—especially outside traditional reimbursement systems—can unlock […]

Tune in to this new episode of MAP to explore New Zealand’s unique healthcare and reimbursement landscape with Dr. Stefan Walzer and health economist Dr. Julius Ohnberger. Learn how PHARMAC combines HTA and payer roles, why equity and Māori health outcomes are central to market access and what global pharma can gain from launching in […]